MAP855 - ≥99% , CAS No.1660107-77-6

CAS: 1660107-77-6 Cat. No.: M649236 Molecular Weight: 564.97
AVAILABLE TO ORDER
GRADE & PURITY ≥99%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
5mg
M649236-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$1,720.90
10mg
M649236-10mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$2,740.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥99% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

MAP855 is a highly potent, selective, ATP-competitive and orally active MEK1/2 kinase inhibitor (MEK1 ERK2 cascade IC 50 =3 nM, pERK EC 50 =5 nM). MAP855 shows equipotent inhibition of wild-type and mutant MEK1/2

In Vitro

MAP855 (compound 30) has single-digit nM inhibition of pERK and proliferation in A375 cells (pERK EC 50 =5 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation Assay Cell Line: A375 cellsConcentration: 0-10 nM Incubation Time: 72 hours Result: Showed single-digit nM inhibition of pERK and proliferation in A375 cells (pERK EC 50 =5 nM).

In Vivo

MAP855 (3 mg/kg for i.v., 10 mg/kg for p.o.; single) has good oral bioavailability and medium clearance in rodents . MAP855 (30 mg/kg; p.o., b.i.d, 14 days) achieves comparable efficacy to trametinib dosed at the mouse MTD without any body weight loss . Pharmacokinetic Parameters of MAP855 in mouse, rat and dog . mouse rat dog CL [mL/min*kg] 32 35 22 V ss [l/kg] 2.6 2.0 1.8 AUC po d.n. [μM*h] 0.4 0.6 1.4 Oral BAV [% F ] 44 65 100 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Wistar Rats Dosage: 3 mg/kg for i.v., 10 mg/kg for p.o. Administration: i.v. and p.o., single Result: Showed good oral bioavailability and medium clearance. Animal Model: A375 Tumor Bearing Mice Dosage: 30 mg/kg Administration: p.o., b.i.d, 14 days Result: Achieved comparable efficacy to trametinib dosed at the mouse MTD without any body weight loss.

Form:Solid

IC50& Target:ERK 5 nM (EC 50 ) MEK1 3 nM (IC 50 )

Specifications

Specifications & Purity
≥99%
Biochemical and Physiological Mechanisms
MAP855 is a highly potent, selective, ATP-competitive and orally active MEK1/2 kinase inhibitor (MEK1 ERK2 cascade IC 50 =3 nM, pERK EC 50 =5 nM). MAP855 shows equipotent inhibition of wild-type and mutant MEK1/2.
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Purity
≥99%
Names and Identifiers
Molecular Weight 564.97

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilityDMSO : 100 mg/mL (177.00 mM; Need ultrasonic)
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.